PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'MRC Centre of Transplantation, Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, Guy\'s Hospital, King\'s College London, London, UK.\', \'Department of Respiratory Science and Infection, Leicester Institute of Chemical and Structural Biology, University of Leicester, Leicester, UK.\', \'Department of Infectious Diseases, School of Immunology and Microbial Sciences, Guy\'s Hospital, King\'s College London, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.15252/emmm.202012642
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 32559343
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
is ?:relation_isRelatedTo_publication of
?:title
  • Rationale for targeting complement in COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all